The significance of haemochromatosis gene mutations in the general population: Implications for screening

Gut

Volumn 43, Issue 6, 1998, Pages 830-836

  Burt, M J ^a   George, P M ^a   Upton, J D ^a   Collett, J A ^a   Frampton, C M A ^a   Chapman, T M ^a   Walmsley, T A ^a   Chapman, B A ^a  

^a CHRISTCHURCH HOSPITAL   (New Zealand)

Author keywords

Haemochromatosis; HFE gene; Iron overload; Screening

Indexed keywords

DNA; FERRITIN; IRON; TRANSFERRIN;

ADULT; ARTICLE; FEMALE; FERRITIN BLOOD LEVEL; GENE FREQUENCY; GENE MUTATION; GENETIC SCREENING; HEMOCHROMATOSIS; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HUMAN TISSUE; IRON BLOOD LEVEL; IRON STORAGE; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TRANSFERRIN BLOOD LEVEL;

EID: 0031793132     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.43.6.830     Document Type: Article

References (49)

1. Edwards CQ, Griffen LM, Goldgar D, et al. Prevalence of hemochromatosis among 11,065 presumably healthy blood donors. N Engl J Med 1988;318:1355-62.
2. Laggett BA, Halliday JW, Brown NN, et al. Prevalence of haemochromatosis amongst asymptomatic Australians. Br J Haematol 1990;74:525-30.
3. Baer DM, Simons JL, Staples RL, et al. Hemochromatosis screening in asymptomatic ambulatory men 30 years of age and older. Am J Med 1995;98:464-8.
4. Smith BN, Kantrowitz W, Grace ND, et al. Prevalence of hereditary hemochromatosis in a Massachusetts corporation: is Celtic origin a risk factor? Hepatology 1997; 25:1439-46.
5. Olsson KS, Ritter B, Rosen U, et al. Prevalence of iron overload in Central Sweden. Acta Med Scand 1983;213:145-50.
6. Olsson KS, Eriksson K, Ritter B, et al. Screening for iron overload using transferrin saturation. Acta Med Scand 1984;215:105-12.
7. Powell LW, Jazwinska E, Halliday JW. Primary iron overload. In: Brock JH, Halliday JW, Pippard MJ, Powell LW, eds. Iron metabolism in health and disease. London: Saunders, 1994:227-70.
8. Edwards CQ, Cartwright GE, Skolnick MH, et al. Homozygosity for hemochromatosis: clinical manifestations. Ann Intern Med 1980;93:519-25.
9. Niederau C, Fischer R, Purschel A, et al. Long-term survival in patients with hereditary hemochromatosis. Gastroenterology 1996;110:1107-19.
10. Niederau C, Fischer R, Sonnenberg A, et al. Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis. N Engl J Med 1985;313: 1256-62.
11. Fargion S, Mandelli C, Piperno A, et al. Survival and prognostic factors in 212 Italian patients with genetic hemochromatosis. Hepatology 1992;15:655-9.
12. Adams PC, Speechley M, Kertesz AE. Long-term survival analysis in hereditary hemochromatosis. Gastroenterology 1991;101:368-72.
13. Feder JN, Gnirke A, Thomas W, et al. A novel MHC class I-like gene is mutated in patients with hereditary hemochromatosis. Nat Genet 1996;13:399-408.
14. Bodmer JG, Parham P, Albert ED, et al. Putting a hold on "HLA-H". Nat Genet 1997;15:234-5.
15. Jazwinska EC, Cullen LM, Busfield F, et al. Haemochromatosis and HLA-H. Nat Genet 1990;14:249-51.
16. Jouanolle AM, Gandon G, Jezequel P, et al. Haemochromtosis and HLA-H. Nat Genet 1996;14:251-2.
17. Beutler E, Gelbart T, West C, et al. Mutation analysis in hereditary hemochromatosis. Blood Cells Mol Dis 1996;22: 187-94.
18. Carella M, D'Ambrosio L, Totara A, et al. Mutation analysis of the HLA-H gene in Italian hemochromatosis patients. Am J Hum Genet 1997;60:828-32.
19. Beutler E. Genetic irony beyond haemochromatosis: clinical effects of HLA-H mutations. Lancet 1997;349:296-7.
20. Martinez PA, Biron C, Blanc F, et al. Compound heterozygotes for hemochromatosis gene mutations: may they help to understand the pathophysiology of the disease? Blood Cells Mol Dis 1997;23:269-76.
21. Scheuer PJ, Williams R, Muir AR. Hepatic pathology in relatives of patients with haemochromatosis. J Pathol Bacteriol 1962;84:53-64.
22. Bassett ML, Halliday JW, Powell LW. Value of hepatic iron measurements in early hemochromatosis and determination of the critical iron level associated with fibrosis. Hepatalogy 1986;6:24-9.
23. Chapman BA, Horton DM, Burt MJ, et al. Investigation of subjects with abnormal iron studies: role of the hepatic iron index. NZ Med J 1994;107:504-7.
24. Talmud P, Tybjaerg-Hansen A, Bhatnagar D, et al. Rapid screening for specific mutations in patients with a clinical diagnosis of familial hypercholesterolaemia. Atherosclerosis 1991;89:137-41.
25. Burt MJ, Upton JD, Morison IM, et al. Molecular analysis of HLA-H gene mutations in New Zealand patients with haemochromatosis. NZ Med J 1997;110:429-32.
26. Cartwright GE, Edwards CQ, Kravitz K, et al. Hereditary hemochromatosis. Phenotypic expression of the disease. N Engl J Med 1979;301:175-9.
27. Simon M, Fauchet R, Hespel JP, et al. Idiopathic hemochromatosis: a study of biochemical expression in 247 heterozygous members of 63 families: evidence for a single major HLA-linked gene. Gastroenterology 1980;78:703-8.
28. Bassett ML, Halliday JW, Powell LW. HLA typing in idiopathic hemochromatosis: distinction between homozygotes and heterozygotes with biochemical expression. Hepatology 1981;1:120-6.
29. Adams PC. Prevalence of abnormal iron studies in heterozygotes for hereditary hemochromatosis: an analysis of 255 heterozygotes. Am J Hematol 1994;45:146-9.
30. Bulaj ZJ, Griffen LM, Jorde LB, et al. Clinical and biochemical abnormalities in people heterozygous for hemochromatosis. N Engl J Med 1996;335:1799-805.
31. Cullen LM, Summerville L, Glassick TV, et al. Neonatal screening for the hemochromatosis defect. Blood 1997;90: 4236.
32. Merryweather-Clarke AT, Pointon JJ, Shearman JD, et al. Global prevalence of putative haemochromatosis mutations. J Med Genet 1997;34:275-8.
33. Bacon BR, Sadiq SA. Hereditary hemochromatosis: presentation and diagnosis in the 1990s. Am J Gastroenterol 1997; 92:784-9.
34. Simon M, Alexandre JL, Fauchet R, et al. The genetics of hemochromatosis. Prog Med Genet 1980;4:135-68.
35. Motulsky AG. Genetics of hemochromatosis. N Engl J Med 1979;301:1291.
36. Kravitz K, Skolnick M, Cannings C, et al. Genetic linkage between hereditary hemochromatosis and HLA. Am J Hum Genet 1979;.31:601-19.
37. Crawford DHG, Powell LW, Leggett BA, et al. Evidence that the ancestral haplotype in Australian hemochromatosis patients may be associated with a common mutation in the gene. Am J Hum Genet 1995;57:362-7.
38. Jazwinska EC, Powell LW. Hemochromatosis and "HLA-H": definite! Hepatology 1997;25:495-6.
39. Kushner JP. Screening for hemochromatosis. Gastroenterology 1995;109:315-16.
40. Powell LW, Summers KM, Board PG, et al. Expression of hemochromatosis in homozygous subjects. Implications for early diagnosis and prevention. Gastroenterology 1990;98: 1625-32.
41. Crawford DHG, Jazwinska EC, Cullen LM, et al. Expression of HLA-linked hemochromatosis in subjects homozygous or heterozygous for the C282Y mutation. Gastroenterology 1998;114:1003-8.
42. Salonen JT, Nyyssonen K, Korpela H, et al. High stored iron levels are associated with excess risk of myocardial infarction in Eastern Finnish men. Circulation 1992;86: 803-11.
43. Olynyk JK, Reddy KR, Di Bisceglie AM, et al. Hepatic iron concentration as a predictor of response to interferon alfa therapy in chronic hepatitis C. Gastroenterology 1995;108: 1104-9.
44. Roberts AG, Whatley SD, Morgan RR, et al. Increased frequency of the haemochromatosis Cys282Tyr mutation in sporadic porphyria cutanea tarda. Lancet 1997;349:321-3.
45. George DK, Goldwurm S, MacDonald GA, et al. Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis. Gastroenterology 1998; 114:311-18.
46. Balan V, Baldus W, Fairbanks V, et al. Screening for hemochromatosis: a cost-effectiveness study based on 12,258 patients. Gastroenterology 1994;107:453-9.
47. Phatak PD, Guzman G, Woll JE, et al. Cost-effectiveness of screening for hereditary hemochromatosis. Arch Intern Med 1994;154:769-76.
48. Adams PC, Gregor JC, Kertesz AE, et al. Screening blood donors for hereditary hemochromatosis: decision analysis model based on a 30-year database. Gastroenterology 1995; 109:177-88.
49. Edwards CQ, Kushner JP. Screening for hemochromatosis. N Engl J Med 1993;328:1616-20.